AMENDMENT TO OPTION #24

(Christopher David, Grant Date February 19, 2016)

Dated as of April 20, 2018

THIS AMENDMENT TO OPTION (the “Amendment”), dated as of the date first set forth above (the “Effective Date”) is entered into by and between Novo Integrated Sciences Inc., a Nevada corporation (the “Company”) and Christopher David (the “Holder” or “Optionee”), an individual. Each of the Company and Holder may be referred to herein individually as a “Party” and collectively as the “Parties.”

WHEREAS, on February 19, 2016 the Company issued to Holder an option to purchase 500,000 shares of common stock of the Company at an exercise price of USD$0.16 (“Option #24” or the “Option”) which Option vested on the 1-year anniversary date of February 19, 2017 and as defined in Section 1(b) of the Option Agreement, is currently set to expire (the “Expiration Date”) on February 19, 2022;

WHEREAS, on February 19, 2016 as part of the Option Agreement #24, the Company issued to the Holder a Certificate of Option which in Paragraph #2 states “The Option expires five (5) years after the date of issue and is exercisable, in whole or in part, at any-time before they expire” which defines the Expiration Date as February 19, 2021;

WHEREAS, the defined Expiration Date in (a) the Option Agreement, Section 1(b); and (b) the Certificate of Option, paragraph 2, is inconsistent;

WHEREAS, Option Agreement #24, Section 1(b), should state “These Options to purchase the Company common stock must be exercised, in whole or in part, on or before February 19, 2021”, which represent five (5) years after the Option #24 Grant Date of February 19, 2016;

WHEREAS, the Parties further desire to amend the option Expiration Date by adding an additional three (3) years to the February 19, 2021 Expiration Date which would provide for an amended Expiration Date of February 19, 2024;

WHEREAS, the Parties now desire to amend the Option, as set forth below; and

NOW, THEREFORE, in consideration of the foregoing, and for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the Parties agree as follows:

[Signatures appear on following page]

IN WITNESS WHEREOF, the Parties have executed this Amendment as of the Effective Date.